InvestorsHub Logo
Followers 138
Posts 23717
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Monday, 04/25/2022 2:24:33 PM

Monday, April 25, 2022 2:24:33 PM

Post# of 665
AXS-07 is a novel, oral, rapidly absorbed, multi-mechanistic, investigational medicine. AXS-07 consists of MoSEIC™ (Molecular Solubility Enhanced Inclusion Complex) meloxicam and rizatriptan.

Interestingly both meloxicam and rizatriptan are FDA approved drugs currently on the market.

Therefore, the FDA may only have minor questions about the chemistry, manufacturing, and controls (“CMC”) issues identified during the FDA’s review of the Company’s New Drug Application (“NDA”) for its AXS-07.


Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AXSM News